Lantheus Holdings (LNTH) Revenue Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) Revenue Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 14.92% |
| 10 | Lantheus Holdings | 7.02 Bn | 6.52 Bn | 230.92 Mn | 1.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23% |
| Dec 31, 2025 | 4.01% |
| Sep 30, 2025 | 1.39% |
| Jun 30, 2025 | -4.07% |
| Mar 31, 2025 | 0.75% |
| Dec 31, 2024 | 2,507.40% |
| Sep 30, 2024 | 18.37% |
| Jun 30, 2024 | 22.50% |
| Mar 31, 2024 | 23.00% |
| Dec 31, 2023 | -94.30% |
| Sep 30, 2023 | 33.71% |
| Jun 30, 2023 | 43.79% |
| Mar 31, 2023 | 44.00% |
| Dec 31, 2022 | 103.12% |
| Sep 30, 2022 | 134.43% |
| Jun 30, 2022 | 121.37% |
| Mar 31, 2022 | 125.79% |
| Dec 31, 2021 | 37.61% |
| Sep 30, 2021 | 15.28% |
| Jun 30, 2021 | 53.10% |